Metabolic Changes Associated With Metformin Potentiates Anti-BCL-2 Inhibitor, Abt-199, and Cdk9 Inhibitor, Bay-1143572 and Reduces Viability of Lymphoma Cells

Hematological Oncology - United Kingdom
doi 10.1002/hon.2439_176
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley